Embla Medical hf Yönetim

Yönetim kriter kontrolleri 3/4

Embla Medical hf CEO'su Sveinn Solvason, Apr2022 tarihinde atandı, in görev süresi 2.58 yıldır. in toplam yıllık tazminatı $ 1.18M olup, şirket hissesi ve opsiyonları dahil olmak üzere 48.8% maaş ve 51.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.016% ine doğrudan sahiptir ve bu hisseler DKK 2.45M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.6 yıl ve 15.8 yıldır.

Anahtar bilgiler

Sveinn Solvason

İcra Kurulu Başkanı

US$1.2m

Toplam tazminat

CEO maaş yüzdesi	48.8%
CEO görev süresi	2.6yrs
CEO sahipliği	0.02%
Yönetim ortalama görev süresi	2.6yrs
Yönetim Kurulu ortalama görev süresi	15.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Sveinn Solvason'un ücretlendirmesi Embla Medical hf'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$69m
Jun 30 2024	n/a	n/a	US$61m
Mar 31 2024	n/a	n/a	US$57m
Dec 31 2023	US$1m	US$576k	US$58m
Sep 30 2023	n/a	n/a	US$52m
Jun 30 2023	n/a	n/a	US$45m
Mar 31 2023	n/a	n/a	US$43m
Dec 31 2022	US$780k	US$409k	US$43m

Tazminat ve Piyasa: Sveinn 'nin toplam tazminatı ($USD 1.18M ), UK pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 2.07M ).

Tazminat ve Kazançlar: Sveinn 'in maaşı son bir yılda %20'den fazla arttı.

CEO

Sveinn Solvason (46 yo)

2.6yrs

Görev süresi

US$1,180,000

Tazminat

Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sveinn Solvason	President & CEO	2.6yrs	US$1.18m	0.016% DKK 2.5m
Ossur Kristinsson	Founder	no data	US$25.00k	Veri yok
Gudny Sveinsdottir	Chief Financial Officer	2.2yrs	Veri yok	Veri yok
Lukas Marklin	Chief Operating Officer	1.4yrs	Veri yok	Veri yok
Edda Luovigsdottir	Investor Relations Director	no data	Veri yok	Veri yok
Margret Fridriksdottir	Executive Vice President of People	no data	US$242.00k	0.0083% DKK 1.3m
Olafur Gylfason	Chief Commercial Officer	no data	US$600.00k	0.0030% DKK 459.8k
Gudjon Karason	Executive Vice President of EMEA & APAC	7yrs	Veri yok	0.023% DKK 3.5m
Christian Robinson	President of Americas	no data	Veri yok	0.0031% DKK 473.6k
Hildur Einarsdottir	Executive Vice President of Research & Development	2.6yrs	Veri yok	0.00014% DKK 21.5k

2.6yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: 0FIW 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Niels Jacobsen	Chairman of the Board	19.8yrs	US$108.00k	0.048% DKK 7.3m
Svafa Gronfeldt	Vice Chairman of the Board	16.8yrs	US$72.00k	Veri yok
Gudbjorg Eggertsdottir	Independent Director	11.7yrs	US$43.00k	0.0062% DKK 944.1k
Arne Nielsen	Director	15.8yrs	US$50.00k	Veri yok
Alberto Esquenazi	Independent Director	3.7yrs	US$43.00k	Veri yok

15.8yrs

Ortalama Görev Süresi

67yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 0FIW 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 15.8 yıldır).

Embla Medical hf Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Less than half of directors are independent

Recent updates

Investor sentiment improves as stock rises 18%

Third quarter 2024 earnings released: EPS: US$0.051 (vs US$0.033 in 3Q 2023)

Less than half of directors are independent

Less than half of directors are independent

Embla Medical hf. Revises Earnings Guidance for the Full Year of 2024

Embla Medical hf. Revises Earnings Guidance for the Full Year of 2024

Less than half of directors are independent

First quarter 2024 earnings released: EPS: US$0.019 (vs US$0.024 in 1Q 2023)

Less than half of directors are independent

Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee

Less than half of directors are independent

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: US$0.14 (vs US$0.10 in FY 2022)

Össur hf. Provides Earnings Guidance for the Year 2024

Less than half of directors are independent

Össur hf. to Report Q1, 2024 Results on Apr 23, 2024

Össur hf., Annual General Meeting, Mar 12, 2025

Less than half of directors are independent

Össur hf. Reaffirms Financial Guidance for the Year 2023

Less than half of directors are independent

Össur hf. Announces Executive Changes

First quarter 2023 earnings released: EPS: US$0.024 (vs US$0.022 in 1Q 2022)

Less than half of directors are independent

Less than half of directors are independent

Össur hf. Provides Earnings Guidance for the Year 2023

Full year 2022 earnings released

Less than half of directors are independent

Össur hf. to Report Q1, 2023 Results on Apr 25, 2023

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: US$0.016 (vs US$0.041 in 3Q 2021)

Less than half of directors are independent

Össur hf. (CPSE:OSSR) acquired Naked Prosthetics.

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: US$0.034 (vs US$0.046 in 2Q 2021)

Össur hf. Revises Earnings Guidance for the Year 2022

Össur hf. Reports Preliminary Earnings Results for the Second Quarter and First Half of 2022

Less than half of directors are independent

Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer, Effective September 1, 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces New R&D Leadership

Less than half of directors are independent

Össur Launches New POWER KNEE

Össur hf. Announces Sales Guidance for the Full Year 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Össur Hf. Announces Earnings Guidance for the Full Year 2021

First quarter 2021 earnings released: EPS US$0.027 (vs US$0.017 in 1Q 2020)

Össur Hf. Provides Financial Guidance for the Full Year 2021

Vice Chairman Kristján Ragnarsson has left the company

Full year 2020 earnings released: EPS US$0.015 (vs US$0.16 in FY 2019)

Revenue misses expectations

Össur hf., Annual General Meeting, Mar 08, 2022

Laboratoires Innothera S.A.S completed the acquisition of Gibaud SAS from Össur hf. (CPSE:OSSR).

Össur Hf. Withdraw Its Financial Guidance for 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş